133 related articles for article (PubMed ID: 18977723)
21. High rates of transmitted drug resistance among newly-diagnosed antiretroviral naïve HIV patients in Northern Greece, data from 2009-2011.
Skoura L; Metallidis S; Pilalas D; Kourelis A; Margariti A; Papadimitriou E; Antoniadou ZA; Chrysanthidis T; Tsachouridou O; Kollaras P; Nikolaidis P; Malisiovas N
Clin Microbiol Infect; 2013 Mar; 19(3):E169-72. PubMed ID: 23331664
[TBL] [Abstract][Full Text] [Related]
22. Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.
Liuzzi G
Scand J Infect Dis Suppl; 2003; 106():90-3. PubMed ID: 15000595
[TBL] [Abstract][Full Text] [Related]
23. Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry.
Diouara AA; Ndiaye HD; Guindo I; Bangoura N; Cissé M; Edmond T; Bougoudogo F; Mboup S; Peeters M; Ayouba A; Kane NC
J Int AIDS Soc; 2014; 17(1):19315. PubMed ID: 25527333
[TBL] [Abstract][Full Text] [Related]
24. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of antiretroviral multidrug resistance in highly active antiretroviral therapy-treated patients with HIV/AIDS between 2004 and 2009 in South Korea.
Choi JY; Kwon OK; Choi BS; Kee MK; Park M; Kim SS
J Clin Virol; 2014 Jun; 60(2):154-60. PubMed ID: 24680255
[TBL] [Abstract][Full Text] [Related]
26. Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.
De Luca A; Vendittelli M; Baldini F; Di Giambenedetto S; Trotta MP; Cingolani A; Bacarelli A; Gori C; Perno CF; Antinori A; Ulivi G
Antivir Ther; 2004 Aug; 9(4):583-93. PubMed ID: 15456090
[TBL] [Abstract][Full Text] [Related]
27. Antiretroviral treatment in correctional facilities.
Pontali E
HIV Clin Trials; 2005; 6(1):25-37. PubMed ID: 15765308
[TBL] [Abstract][Full Text] [Related]
28. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
[TBL] [Abstract][Full Text] [Related]
29. High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
Fofana DB; Soulié C; Baldé A; Lambert-Niclot S; Sylla M; Ait-Arkoub Z; Diallo F; Sangaré B; Cissé M; Maïga IA; Fourati S; Koita O; Calvez V; Marcelin AG; Maïga AI
J Antimicrob Chemother; 2014 Sep; 69(9):2531-5. PubMed ID: 24855120
[TBL] [Abstract][Full Text] [Related]
30. Short communication: east meets west: a description of HIV-1 drug resistance mutation patterns of patients failing first line therapy in PEPFAR clinics from Uganda and Nigeria.
Crawford KW; Wakabi S; Kibuuka H; Magala F; Keshinro B; Okoye I; Akintunde E; Hamm TE
AIDS Res Hum Retroviruses; 2014 Aug; 30(8):796-9. PubMed ID: 24798614
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.
Murillo W; de Rivera IL; Parham L; Jovel E; Palou E; Karlsson AC; Albert J
HIV Med; 2010 Feb; 11(2):95-103. PubMed ID: 19686436
[TBL] [Abstract][Full Text] [Related]
32. Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon.
Fokam J; Salpini R; Santoro MM; Cento V; Perno CF; Colizzi V; Ndumbe PM; Fokunang Ntungen C; Ndiang Tetang SM; Nanfack AJ; Takou Komego DA; Cappelli G
Pediatr Infect Dis J; 2011 Dec; 30(12):1062-8. PubMed ID: 21817951
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV-1-infected patients with virological failure.
Llibre JM; Schapiro JM; Clotet B
Clin Infect Dis; 2010 Mar; 50(6):872-81. PubMed ID: 20158400
[TBL] [Abstract][Full Text] [Related]
35. Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi.
Luebbert J; Tweya H; Phiri S; Chaweza T; Mwafilaso J; Hosseinipour MC; Ramroth H; Schnitzler P; Neuhann F
Clin Infect Dis; 2012 Aug; 55(3):441-8. PubMed ID: 22573849
[TBL] [Abstract][Full Text] [Related]
36. Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.
Metzner KJ; Giulieri SG; Knoepfel SA; Rauch P; Burgisser P; Yerly S; Günthard HF; Cavassini M
Clin Infect Dis; 2009 Jan; 48(2):239-47. PubMed ID: 19086910
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
De Luca A; Hamers RL; Schapiro JM
J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
[TBL] [Abstract][Full Text] [Related]
38. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
[TBL] [Abstract][Full Text] [Related]
39. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.
von Wyl V; Yerly S; Bürgisser P; Klimkait T; Battegay M; Bernasconi E; Cavassini M; Furrer H; Hirschel B; Vernazza PL; Francioli P; Bonhoeffer S; Ledergerber B; Günthard HF;
Clin Infect Dis; 2009 Apr; 48(7):979-87. PubMed ID: 19228107
[TBL] [Abstract][Full Text] [Related]
40. Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir.
Trotta MP; Bonfigli S; Ceccherini-Silberstein F; Bellagamba R; D'Arrigo R; Soldani F; Zaccarelli M; Concetta Bellocchi M; Lorenzini P; Marconi P; Boumis E; Forbici F; Comandini UV; Tozzi V; Narciso P; Federico Perno C; Antinori A
J Med Virol; 2006 May; 78(5):535-41. PubMed ID: 16555278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
